$33.83
-0.43-1.27%
Last update: 10:29 AM
15 minutes delayed
Comments
Loading...
Veracyte (VCYT) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestVeracyte (NASDAQ:VCYT) Stock Quotes, Forecast and News Summary
Veracyte Stock (NASDAQ: VCYT) stock price, news, charts, stock research, profile.
| Open | $34.36 |
| Close | - |
| Volume / Avg. | 97.94K / 967.29K |
| Day Range | $33.57 - $34.73 |
| 52 Wk Range | 18.61 - 35.51 |
| Market Cap | $2.60B |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 61 |
| Short Interest | 4.25% |
| Days to Cover | 4.59 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Veracyte Inc
Sector
Health Care
Industry
Biotechnology
Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services ...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Veracyte (VCYT) stock?
You can purchase shares of Veracyte (NASDAQ:VCYT) through any online brokerage.
Who are Veracyte (VCYT) competitors?
Other companies in Veracyte’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Twist Bioscience (NASDAQ:TWST), SpringWorks Therapeutics (NASDAQ:SWTX), PTC Therapeutics (NASDAQ:PTCT) and Protagonist Therapeutics (NASDAQ:PTGX).
What is the forecast, or price target, for Veracyte (VCYT) stock?
Veracyte has a consensus price target of $32.17.
What is the current price for Veracyte (VCYT)?
The stock price for Veracyte (NASDAQ: VCYT) is $33.825 last updated September 24, 2024 at 10:29 AM EDT.
Does Veracyte (VCYT) pay a dividend?
There are no upcoming dividends for Veracyte.
When is Veracyte (NASDAQ:VCYT) reporting earnings?
Veracyte’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
Is Veracyte (VCYT) going to split?
There is no upcoming split for Veracyte.
What sector and industry does Veracyte (VCYT) operate in?
Veracyte is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.